Synergistic induction of apoptosis by a polo-like kinase 1 inhibitor and microtubule-interfering drugs in Ewing sarcoma cells. - Wikidata - wikimedia - TriplyDB

Synergistic induction of apoptosis by a polo-like kinase 1 inhibitor and microtubule-interfering drugs in Ewing sarcoma cells.

Synergistic induction of apoptosis by a polo-like kinase 1 inhibitor and microtubule-interfering drugs in Ewing sarcoma cells.

http://www.wikidata.org/entity/Q38844740

about

Targeting protein kinases to reverse multidrug resistance in sarcoma.Volasertib suppresses the growth of human hepatocellular carcinoma in vitro and in vivo.The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models.Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor.miR-125b regulates cell progression in chronic myeloid leukemia via targeting BAK1 Eribulin alone or in combination with the PLK1 inhibitor BI 6727 triggers intrinsic apoptosis in Ewing sarcoma cell lines.Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.Identification of volasertib-resistant mechanism and evaluation of combination effects with volasertib and other agents on acute myeloid leukemia.Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.

P2860

Q36527950-17252DA0-170A-4DEF-ACF8-B7EA43883D3A Q37447866-E6FF6E74-B031-4FDC-AC0C-A4A97A0F4809 Q37701672-D2466D29-3547-46AD-AC99-83FA39A0B099 Q38739235-2017FCBB-49B2-4684-8623-65C92EC967F6 Q38824242-234EB62C-61C7-4FF2-B1E2-A75134A34BB5 Q40683422-E003335D-EF87-43F2-9B0D-B436F00D733B Q41592750-4BF1D483-AEC6-4DFE-A03E-B45E267855E2 Q46023921-3B3BEEA0-F781-4932-9BBD-0877C6A610C1 Q47151856-AD551079-647B-4867-AD7A-6FB7516A0730 Q50296864-30FBEF08-52C8-47DC-9A01-CCB00E6651CF

P2860

Synergistic induction of apoptosis by a polo-like kinase 1 inhibitor and microtubule-interfering drugs in Ewing sarcoma cells.

http://www.wikidata.org/entity/Q38844740

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Synergistic induction of apopt ...... drugs in Ewing sarcoma cells.

@en

type

label

Synergistic induction of apopt ...... drugs in Ewing sarcoma cells.

@en

prefLabel

Synergistic induction of apopt ...... drugs in Ewing sarcoma cells.

@en

P1433

Q38844740-3792467A-F97A-4E43-84E9-E67DF5BB4A41

P1476

Q38844740-9D29BE97-B1B8-4F74-A95A-DC207AD67388

P2093

Q38844740-382FA263-EE5C-4BD2-B1E4-5465ECEA90AA

Q38844740-A7D49F2E-1B65-4F31-8EB2-88ABC90F6C03

Q38844740-FE9701D7-ED81-4932-8122-C94D8442A09A

P2860

Q38844740-14280711-38D3-492D-A365-0C976B6EC21D

Q38844740-192EB5AD-4D31-4D85-A485-5149854CAF8A

Q38844740-30E4808F-2DF4-43AF-9DFA-91E3F0952EF9

Q38844740-3461F8DD-E380-4CEC-9C02-C022199944F2

Q38844740-41850A91-074B-472A-94A3-2BBE33EBD706

Q38844740-463A025E-1513-4770-8C2D-D96015A2391B

Q38844740-47F0AD7F-1FDE-447F-B746-DBEDC3A8BD4F

Q38844740-4F18922A-BC27-4F0E-BC3F-08B44743BD08

Q38844740-5BD9892E-3690-4AC7-807F-16091D73FD14

Q38844740-61C83D4D-3C8C-447B-8198-6395D6E8EA33

P304

Q38844740-7DD95D34-7501-4F29-8820-5CB3BC29654D

P31

Q38844740-B777D746-C647-441B-B376-C3A6F9738F04

P356

Q38844740-B50E666A-CDEB-409F-BD76-2F76F73B7514

P433

Q38844740-6C35BBE6-AE62-4124-8A7A-BECE88038E7A

P478

Q38844740-63746DE9-0B21-4F58-AC62-8E872AD927CF

P50

Q38844740-67CED691-87C4-4D54-9214-B4DC3158A121

P577

Q38844740-79B18CFB-A857-41F7-871B-2BE8BD703313

P698

Q38844740-D6FE5189-77D4-49CA-8DEB-37E4427EFDAE

P356

P1433

International Journal of Cancer

P1476

Synergistic induction of apopt ...... drugs in Ewing sarcoma cells.

@en

P2093

Lilly Magdalena Weiß

http://www.w3.org/2001/XMLSchema#string

Manuela Hugle

http://www.w3.org/2001/XMLSchema#string

Sarah Romero

http://www.w3.org/2001/XMLSchema#string

P2860

Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway

Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis

The Bcl-2 apoptotic switch in cancer development and therapy

Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy

Apoptosis: controlled demolition at the cellular level

Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.

Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas.

Targeting mitochondria for cancer therapy.

Histone H3 phosphorylation and cell division.

Initial testing (stage 1) of the Polo-like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing Program.

P304

497-506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.29725

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26260582

http://www.w3.org/2001/XMLSchema#string